A new $16,000 postpartum depression drug is here: How will insurers handle it?
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish ...
Mar 15, 2024
0
1